Astera Labs (NASDAQ:ALAB) Cut to “Hold” at Zacks Research

Zacks Research downgraded shares of Astera Labs (NASDAQ:ALAB) from a strong-buy rating to a hold rating in a research report sent to investors on Monday,Zacks reports.

Several other research firms have also commented on ALAB. Bank of America raised their target price on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Stifel Nicolaus boosted their price target on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. UBS Group restated a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Finally, Citigroup reaffirmed a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Twelve analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $348.33.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $382.25 on Monday. Astera Labs has a one year low of $97.89 and a one year high of $499.48. The firm has a market cap of $66.32 billion, a price-to-earnings ratio of 189.23 and a beta of 3.68. The firm’s fifty day moving average is $315.87 and its two-hundred day moving average is $288.40.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period last year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts predict that Astera Labs will post 2.7 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total value of $2,472,990.24. Following the sale, the director directly owned 3,309 shares of the company’s stock, valued at approximately $909,842.64. This trade represents a 73.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the sale, the director owned 253,863 shares of the company’s stock, valued at $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 396,059 shares of company stock worth $122,605,660 in the last ninety days. 10.40% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in ALAB. Banque Cantonale Vaudoise grew its position in shares of Astera Labs by 85.9% in the first quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock valued at $766,000 after purchasing an additional 3,229 shares during the period. Amazon Com Inc. acquired a new position in shares of Astera Labs during the 2nd quarter worth about $134,172,000. Edgestream Partners L.P. acquired a new position in shares of Astera Labs during the 1st quarter worth about $1,891,000. Lido Advisors LLC raised its position in shares of Astera Labs by 123.4% during the 1st quarter. Lido Advisors LLC now owns 27,477 shares of the company’s stock worth $3,012,000 after purchasing an additional 15,180 shares during the last quarter. Finally, Strs Ohio lifted its stake in Astera Labs by 996.3% in the 1st quarter. Strs Ohio now owns 33,086 shares of the company’s stock valued at $3,626,000 after buying an additional 30,068 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Fubon initiated coverage of Astera Labs with a $500 price target, implying further upside from the current trading level and reflecting confidence in the company’s role in AI connectivity infrastructure. Fubon starts coverage with USD 500 target for Astera Labs stock
• Positive Sentiment: Astera Labs recently rallied as investors continued to favor companies benefiting from accelerating demand for AI data-center and rack-scale connectivity products. The company’s latest reported quarter also showed strong momentum, including 104.5% year-over-year revenue growth and an earnings beat.
• Neutral Sentiment: Astera Labs will release third-quarter 2026 results after the market closes on November 3, 2026, followed by a conference call. The event is a key near-term catalyst because investors will look for evidence that growth and guidance can justify the stock’s premium valuation. Astera Labs Announces Conference Call to Review Third Quarter 2026 Financial Results
• Negative Sentiment: Zacks Research downgraded ALAB from “strong buy” to “hold.” The change likely contributed to selling pressure by highlighting that much of the AI-growth optimism may already be reflected in the share price. Zacks Research Downgrades Astera Labs to Hold
• Negative Sentiment: Analyst commentary also cautions that Astera Labs’ 118% year-to-date advance has produced a rich valuation, while rising costs and competition—including challenges from Marvell’s partnerships with Nvidia and Microsoft—could pressure future growth and margins. Should You Buy, Sell, or Hold ALAB Stock After a 118% YTD Rise?

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.